24/7 Vacations Web Search

  1. Ads

    related to: eliquis patient assistance program bristol-myers squibb

Search results

  1. Results from the 24/7 Vacations Content Network
  2. Apixaban - Wikipedia

    en.wikipedia.org/wiki/Apixaban

    Apixaban. Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. [6] [7] [8] Specifically, it is used to prevent blood clots following hip or knee replacement and in those with a ...

  3. Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?

    www.aol.com/bristol-myers-squibb-good-dividend...

    A buy now. At recent prices, you can scoop up shares of Bristol Myers Squibb for about 8.3 times trailing free cash flow. This multiple is so low that long-term investors could realize market ...

  4. Bristol Myers plans to double experimental treatments to ...

    www.aol.com/news/bristol-myers-plans-double...

    Bristol and partner Pfizer's blood thinner Eliquis was also on the list of 10 drugs that will be subject to the first-ever price negotiations by the U.S. Medicare health program.

  5. Bristol Myers Squibb - Wikipedia

    en.wikipedia.org/wiki/Bristol_Myers_Squibb

    The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

  6. Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs ...

    www.aol.com/finance/bristol-myers-squibb...

    Friday, Bristol Myers Squibb & Co (NYSE:BMY) posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for ...

  7. U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the ... - AOL

    www.aol.com/news/2013-01-02-us-fda-approves...

    In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-Myers Squibb.

  1. Ads

    related to: eliquis patient assistance program bristol-myers squibb